Skip to main content
Fig. 2 | EJNMMI Research

Fig. 2

From: A comparative study of standardized quantitative and visual assessment for predicting tumor volume and outcome in newly diagnosed diffuse large B-cell lymphoma staged with 18F-FDG PET/CT

Fig. 2

Progression-free survival (PFS) and overall survival (OS) using automated metabolic tumor volume (MTV) measurements (a, b, e, f), IPI (c, g) vs. visual assessment of prognosis by expert readers (d, h). As seen, the visual PET assessment of prognosis significantly outperformed both the automated PET metrics as well as the prognosis by the treating hematologist (IPI)

Back to article page